Tenaya Therapeutics Financial Overview
Tenaya Therapeutics's market cap is currently $151.66M. The company's EPS TTM is $-0.12; its P/E ratio is -0.96; Tenaya Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
